Ask Warren

T Scientific

057680 · KOSDAQ · ₩057680 · 티사이언티픽

₩1,368▼ ₩42 (2.98%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩7B₩6.2B₩13B₩8.5B₩8.1B₩7B₩16B₩8.7B
Cost of sales₩5B₩4.5B₩9.1B₩5.8B₩5.6B₩4.8B₩13B₩6.1B
Gross profit₩2B₩1.7B₩3.7B₩2.7B₩2.4B₩2.3B₩3.4B₩2.6B
Operating income−₩536M−₩1B₩1.2B−₩51M₩40M−₩888M−₩8.6B−₩845M
Net income−₩677M−₩1B₩254M₩95M₩1.6B−₩3.5B₩1.7B−₩4.4B
Net income to shareholders−₩636M−₩1B₩404M₩154M₩1.6B−₩3.5B₩1.2B−₩4.3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩198B₩196B₩201B₩161B₩160B₩163B₩163B₩160B
Current assets₩24B₩24B₩29B₩25B₩23B₩29B₩23B₩24B
Cash and equivalents₩12B₩9.6B₩12B₩8.6B₩9.8B₩14B₩3.1B₩4.7B
Total liabilities₩27B₩28B₩32B₩21B₩20B₩24B₩24B₩27B
Current liabilities₩20B₩12B₩16B₩12B₩11B₩17B₩23B₩24B
Borrowings₩5.7B₩5.5B₩5.3B₩4.5B₩4.3B₩3.5B₩1.3B₩5.6B
Total equity₩170B₩168B₩169B₩140B₩140B₩139B₩139B₩132B
Shareholders' equity₩172B₩169B₩170B₩141B₩141B₩141B₩140B₩133B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩688M−₩2.6B₩3.4B−₩1.1B₩603M−₩2.1B−₩2.1B−₩2.9B
Capital spending₩183M₩37M₩2.6M₩13M₩86M−₩19M−₩26M₩24M
Free cash flow−₩871M−₩2.7B₩3.4B−₩1.2B₩516M−₩2.2B−₩2.1B−₩2.9B

Consolidated where available. Amounts in won.

Also known as: T Scientific / 티사이언티픽 / 057680 / KRX:057680

Source: KRX statistical information